Efficacy and Safety of Androgel in the Treatment of Hypogonadal and Low Testosterone Men With Type 2 Diabetes

This study has been completed.

Study NCT00141492 Information provided by Solvay Pharmaceuticals

First Received: August 30, 2005 Last Updated: January 29, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	No date given